Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver - Update 2020 - WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS.

Dietrich, Christoph F; Nolsøe, Christian Pállson; Barr, Richard G; Berzigotti, Annalisa; Burns, Peter N; Cantisani, Vito; Chammas, Maria Cristina; Chaubal, Nitin; Choi, Byung Ihn; Clevert, Dirk-André; Cui, Xinwu; Dong, Yi; D'Onofrio, Mirko; Fowlkes, J Brian; Gilja, Odd Helge; Huang, Pintong; Ignee, Andre; Jenssen, Christian; Kono, Yuko; Kudo, Masatoshi; ... (2020). Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver - Update 2020 - WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultraschall in der Medizin, 41(5), pp. 562-585. Thieme 10.1055/a-1177-0530

[img] Text
a-1177-0530.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (666kB) | Request a copy

The present, updated document describes the fourth iteration of recommendations for the hepatic use of contrast enhanced ultrasound (CEUS), first initiated in 2004 by the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB). The previous updated editions of the guidelines reflected changes in the available contrast agents and updated the guidelines not only for hepatic but also for non-hepatic applications.The 2012 guideline requires updating as previously the differences of the contrast agents were not precisely described and the differences in contrast phases as well as handling were not clearly indicated. In addition, more evidence has been published for all contrast agents. The update also reflects the most recent developments in contrast agents, including the United States Food and Drug Administration (FDA) approval as well as the extensive Asian experience, to produce a truly international perspective.These guidelines and recommendations provide general advice on the use of ultrasound contrast agents (UCA) and are intended to create standard protocols for the use and administration of UCA in liver applications on an international basis to improve the management of patients.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology

UniBE Contributor:

Berzigotti, Annalisa

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0172-4614

Publisher:

Thieme

Language:

English

Submitter:

Rahel Fuhrer

Date Deposited:

19 Nov 2020 15:22

Last Modified:

19 Nov 2020 15:29

Publisher DOI:

10.1055/a-1177-0530

PubMed ID:

32707595

BORIS DOI:

10.7892/boris.148169

URI:

https://boris.unibe.ch/id/eprint/148169

Actions (login required)

Edit item Edit item
Provide Feedback